Sign inGet started

KRIEGSMAN STEVEN A

Insider CIK 1197482 · CATS Director · GALE Director · CYTR President, CEO, Board Chairman, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CYTR CYTRX CORP M Exercise deriv2020-08-072020-08-133,000,000— $00SEC↗
CYTR CYTRX CORP M Exercise2020-08-072020-08-133,000,000$0.26 $780.0K4,832,217SEC↗
CYTR CYTRX CORP F Tax w/h2020-08-072020-08-131,164,179$0.67 $780.0K3,668,038SEC↗
CYTR CYTRX CORP A Award deriv2019-12-132019-12-173,000,000— $03,000,000SEC↗
CYTR CYTRX CORP A Award deriv2017-12-152017-12-19208,334— $0208,334SEC↗
CYTR CYTRX CORP A Award2017-12-152017-12-19387,597$1.75 $678.3K387,597SEC↗
CYTR CYTRX CORP A Award deriv2016-12-152016-12-191,250,000— $01,250,000SEC↗
CYTR CYTRX CORP A Award deriv2016-12-152016-12-201,250,000— $01,250,000SEC↗
CYTR CYTRX CORP A Award2016-12-152016-12-202,325,581$0.43 $1000.0K2,325,581SEC↗
CYTR CYTRX CORP A Award deriv2015-12-152015-12-171,000,000— $01,000,000SEC↗
GALE Galena Biopharma, Inc. A Award deriv2015-06-192015-06-23100,000— $0100,000SEC↗
CATS CATASYS, INC. A Award deriv2015-02-172015-04-28200,000— $0200,000SEC↗
CYTR CYTRX CORP A Award deriv2014-12-152014-12-16600,000— $0600,000SEC↗
GALE Galena Biopharma, Inc. M Exercise deriv2014-01-232014-04-0950,000— $00SEC↗
GALE Galena Biopharma, Inc. M Exercise deriv2014-01-232014-04-09100,000— $00SEC↗
GALE Galena Biopharma, Inc. S Sale2014-01-232014-04-09150,000$5.92 $888.0K5,000SEC↗
GALE Galena Biopharma, Inc. M Exercise2014-01-232014-04-0950,000$2.31 $115.5K155,000SEC↗
GALE Galena Biopharma, Inc. M Exercise2014-01-232014-04-09100,000$1.18 $118.0K105,000SEC↗
GALE Galena Biopharma, Inc. M Exercise deriv2014-01-222014-01-22200,000— $00SEC↗
GALE Galena Biopharma, Inc. M Exercise deriv2014-01-222014-01-2250,000— $00SEC↗
GALE Galena Biopharma, Inc. S Sale2014-01-222014-01-22250,000$6.13 $1.53M5,000SEC↗
GALE Galena Biopharma, Inc. M Exercise2014-01-222014-01-2250,000$0.72 $36.0K255,000SEC↗
GALE Galena Biopharma, Inc. M Exercise2014-01-222014-01-22200,000$1.18 $236.0K205,000SEC↗
GALE Galena Biopharma, Inc. M Exercise deriv2014-01-172014-01-22200,000— $00SEC↗
GALE Galena Biopharma, Inc. M Exercise2014-01-172014-01-22200,000$0.85 $170.0K205,000SEC↗
GALE Galena Biopharma, Inc. S Sale2014-01-172014-01-22200,000$7.00 $1.40M5,000SEC↗
CYTR CYTRX CORP A Award deriv2013-12-102013-12-11925,000— $0925,000SEC↗
GALE Galena Biopharma, Inc. A Award deriv2013-11-262013-11-27200,000— $0200,000SEC↗
CYTR CYTRX CORP A Award deriv2013-03-082013-03-1274,176— $074,176SEC↗
GALE Galena Biopharma, Inc. A Award deriv2013-01-292013-01-3150,000— $050,000SEC↗
4WA@GWGZ CYTRX CORP A Award deriv2012-12-102012-12-11500,000— $0500,000SEC↗
CYTR CYTRX CORP P Buy2012-02-232012-02-24105,517$0.33 $34.8K4,179,776SEC↗
CYTR CYTRX CORP P Buy2012-02-222012-02-2453,159$0.31 $16.5K4,074,259SEC↗
GALE Galena Biopharma, Inc. A Award deriv2012-01-122012-01-1750,000— $050,000SEC↗